Efficacy and Safety of Imatinib Mesylate (Glivec™) in Combination With Interferon-Α (IFN-α) in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL)

Leukemia - United Kingdom
doi 10.1038/sj.leu.2403093
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Therapy With Imatinib Mesylate (Glivec) Preceding Allogeneic Stem Cell Transplantation (SCT) in Relapsed or Refractory Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ALL)

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2002English

Result of High-Dose Imatinib Mesylate in Patients With Philadelphia Chromosome--Positive Chronic Myeloid Leukemia After Failure of Interferon-

Blood
BiochemistryImmunologyCell BiologyHematology
2003English

Pcn137 - The Economic Evaluation of Imatinib Combined With Chemotherapy for Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in China

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Lymphoblasts Expressing Surface IgM in the Absence of Kappa and Lambda in Philadelphia Positive Acute Lymphoblastic Leukemia: Philadelphia Chromosome Positive Transitional Pre-B Acute Lymphoblastic Leukemia

Clinical Case Reports and Reviews
2018English

Secondary Myelodysplastic Syndrome in a Patient With Philadelphia-Positive Acute Lymphoblastic Leukemia After Achieving a Major Molecular Response With hyperCVAD Plus Imatinib Mesylate

Leukemia Research
Cancer ResearchOncologyHematology
2008English

Current Paradigms in the Management of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia in Adults

American Journal of Hematology
Hematology
2017English

Effective Re-Induction Therapy With Dasatinib and Clofarabine in Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Drugs and Therapy Studies
2012English

Clinical Efficacy and Safety of Imatinib in the Management of Ph+ Chronic Myeloid or Acute Lymphoblastic Leukemia in Chinese Patients

OncoTargets and Therapy
OncologyPharmacology
2014English

Role of Tyrosine Kinase Inhibitors in the Management of Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia

Current Hematologic Malignancy Reports
Cancer ResearchOncologyHematology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy